Clinical Trial Update: A Phase II Trial of PF-00299804 in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of Esophagus [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase II trial evaluating PF-00299804 in patients with metastatic or recurrent Esophageal Squamous Cell Carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• PF-00299804

Snippet

Sponsor: Yonsei University | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED